8 Best Life Sciences Penny Stocks to Buy

7. Maravai LifeSciences Holdings Inc. (NASDAQ:MRVI)

Maravai LifeSciences Holdings Inc. (NASDAQ:MRVI) is one of the 8 Best Life Sciences Penny Stocks to Buy.

As of the April 8 close, Maravai LifeSciences Holdings Inc. (NASDAQ:MRVI) had a moderately bullish consensus sentiment. The stock received coverage from 6 analysts, 3 of whom assigned Buy ratings and 3 gave Hold calls. With no Sell rating, the stock has a projected median 1-year price target of $4, which leads to an upside potential of more than 30%.

On March 26, the news portal Ad Hoc News reported that Maravai LifeSciences Holdings Inc. (NASDAQ:MRVI) had been exhibiting volatility amid trading activity in the stock options, as well as rating downgrades by some analysts. This reflects on investor skepticism at a time when the company aims for cost reduction and turning EBITDA positive during the ongoing year.

In late February, Maravai LifeSciences Holdings Inc. (NASDAQ:MRVI) stated in its forecast of 2026 earnings that total revenue was expected to range between $200 million and $210 million for the upcoming year. This represents growth between 8% to 13% when compared to 2025 revenue levels. TriLink and Cygnus were projected to record a low single-digit growth rate for the same year.

The target range for the full year 2026 adjusted EBITDA of the company was set at $18-$20 million, along with 120% increase in gross margins compared to the prior year. As per the firm’s Chief Financial Officer, Rajesh Asarpota, operating expenses for the company would be reduced by approximately 13%. It has been revealed that general and administrative expenses will fall by about 18%, and sales and marketing expenses will witness a reduction of about 13%, while there will be an increase in research and development costs.

Maravai LifeSciences Holdings Inc. (NASDAQ:MRVI) offers products that help with developing therapeutics, gene therapies, vaccines, and diagnostics. The company is engaged in the production and sales of oligonucleotide therapy and CleanCap capping technology, as well as the production of analytical products used in the biologic manufacturing process. It caters to biopharmaceutical and scientific research companies, and more.